查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1606598

臨床實驗現場管理組織市場：按階段、服務、治療領域和最終用戶 - 2025-2030 年全球預測

Clinical Trials Site Management Organizations Market by Phase (Phase I, Phase II, Phase III), Services (Onsite Monitoring, Project Management, Regulatory Compliance), Therapeutic Areas, End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 191 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年臨床實驗現場管理組織市場規模為68.6億美元，預計2024年將達到73.1億美元，複合年成長率為6.85%，到2030年將達到109.1億美元。

臨床實驗管理組織 (SMO) 透過代表臨床試驗贊助者管理和進行研究，在臨床試驗的管理和運作中發揮重要作用。 SMO 的業務範圍包括選址、病患招募、資料管理和法規遵循，促進製藥和臨床實驗的臨床測試流程。對 SMO 的需求源於臨床測試日益複雜、地理擴張以及更有效地招募和保留患者的需要。應用廣泛跨越臨床測試階段 (I-IV)，重點關注腫瘤學、心臟病學、中樞神經系統和感染疾病等治療領域。生物製藥公司、學術機構和受託研究機構的最終用途需求很高。

主要市場統計
基準年[2023] 68.6億美元
預測年份 [2024] 73.1億美元
預測年份 [2030] 109.1億美元
複合年成長率（%） 6.85%

主要成長動力包括研發活動增加導致臨床試驗數量活性化、外包趨勢以及人工智慧和巨量資料分析等技術進步推動的臨床實驗試驗地點和患者招募的加強選擇。潛在的商機在於擴大與 CRO 的夥伴關係關係，並在高需求的治療領域開發專業服務。利用這些優勢的建議包括策略聯盟和對數位解決方案的投資，以提高實驗室效率並降低成本。然而，市場面臨嚴格的監管要求、延遲的檢驗時間表以及導致定價挑戰的競爭壓力等限制。此外，由於實施的複雜性和成本，整合新技術也是一項挑戰。

創新部分包括以患者為中心的測試設計、自適應測試框架以及用於即時監控的穿戴式技術的整合。探索分散的臨床測試模型可以提供競爭優勢。預計該市場將在全球化和罕見疾病的推動下呈現動態成長，需要不斷適應的研究和管理策略。公司必須專注於建立強大的網路，提高資料分析能力，並培養與技術提供者的合作夥伴關係，以確保可擴展性和對不斷變化的市場需求的應對力。

市場動態：揭示快速發展的臨床實驗站點管理組織市場中的關鍵市場洞察

臨床實驗現場管理組織市場正因供需的動態交互作用而轉變。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 健康問題的風險增加並增加實驗室檢測
    • 增加對全球藥物研究的私人和公共投資
    • 需要強大的臨床實驗室法律規範和具有成本效益的管理服務
  • 市場限制因素
    • 與多中心溝通和協調相關的複雜性
  • 市場機會
    • 將尖端技術融入臨床實驗設施管理業務
    • 由於醫療基礎設施的改善而擴大臨床測試和研究設施
  • 市場問題
    • 關於病患資料和安全的道德問題

波特的五力：駕馭臨床實驗管理組織市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架描述了評估公司競爭和探索策略機會的清晰方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢、解決弱點並避免潛在的挑戰，以確保更強大的市場地位。

PESTLE分析：了解臨床實驗現場管理組織市場的外部影響

外部宏觀環境因素在塑造臨床實驗中心管理組織市場的績效動態發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析：了解臨床實驗設施管理組織市場的競爭狀況

臨床實驗現場管理組織市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示自己的競爭定位。該分析揭示了市場集中、細分和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣：臨床實驗現場管理組織市場供應商的績效評估

FPNV 定位矩陣是評估臨床實驗現場管理組織市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議：繪製臨床實驗現場管理組織市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對臨床實驗設施管理組織市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

該報告對涵蓋關鍵焦點細分市場的市場進行了全面分析。

1.市場滲透率：對當前市場環境的詳細審查，主要企業的廣泛資料，評估他們在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有細分市場的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策。

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品和地區提供最佳投資機會？

3. 塑造市場的關鍵技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 健康問題的風險增加並增加實驗室檢測
      • 全球私人和公共對藥物研究的投資增加
      • 需要強大的臨床實驗室法規結構和具有成本效益的管理服務
    • 抑制因素
      • 與跨多個地點的溝通和協調相關的複雜性
    • 機會
      • 將先進技術融入臨床實驗室管理業務
      • 由於醫療基礎設施的改善而擴大臨床測試和研究設施
    • 任務
      • 關於病患資料和安全的道德問題
  • 市場區隔分析
    • 第三階段：第三階段測試需要嚴格的資料收集和參與者管理
    • 治療領域：腫瘤學研究固有的複雜性以及快速開發週期和廣泛的多機構協調的需要
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 經濟
    • 社會
    • 科技
    • 法律
    • 環境

第6章臨床實驗現場管理機構市場：分階段

  • 介紹
  • 第一階段
  • 第二階段
  • 第三階段
  • 第四階段

第7章臨床實驗中心管理組織市場：依服務分類

  • 介紹
  • 現場監控
  • 計劃管理
  • 監理合規性
  • 現場管理

第8章臨床實驗中心管理組織市場：依治療領域

  • 介紹
  • 心臟病學
  • 中樞神經系統
  • 內分泌
  • 腫瘤學
  • 疼痛管理

第9章臨床實驗現場管理機構市場：依最終使用者分類

  • 介紹
  • 生技公司
  • 製藥公司
  • 研究/學術機構

第10章美洲臨床實驗現場管理組織市場

  • 介紹
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太臨床實驗現場管理組織市場

  • 介紹
  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章歐洲、中東和非洲的臨床實驗設施管理組織市場

  • 介紹
  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • Pinnacle Clinical Research 收購 Jubilee，擴大西海岸業務並擴展治療專業知識
    • IQVIA 的創新平台透過整合關鍵研究系統簡化臨床測試管理
    • AHP 投資 Prority Clinical Research，以加強治療專業知識並擴展跨策略地點的站點網路
    • Ichor生命科學推出Ichor臨床檢測服務拓展業務領域
    • LEO Pharma 與 ICON plc 之間的策略聯盟加強創新皮膚病學臨床測試
    • Neutra 簽署收購私人臨床研究的基本協議
  • 戰略分析和建議
    • IQVIA 有限公司

公司名單

  • Accel Clinical Services
  • Accelagen
  • Altasciences
  • Celerion
  • ClinChoice
  • Clinical Development Solutions
  • CMIC HOLDINGS Co., LTD.
  • Criterium, Inc.
  • FIDELIS RESEARCH AD by BioIVT
  • FOMAT Medical Research Inc.
  • George Clinical Pty Ltd
  • Grand Pacific CRO
  • ICON PLC
  • IQVIA Inc.
  • KV Clinical Research Services
  • LEK Consulting LLC
  • Medigence Solutions Pvt Ltd.
  • Novotech Health Holdings
  • Parexel International Corporation
  • PPD Inc. by Thermo Fisher Scientific Inc.
  • PROMETRIKA, LLC.
  • ProTrials Research, Inc.
  • Red Maple Trials Inc.
  • SGS SA
  • Veristat, LLC.
  • Vial Health Technology, Inc.
  • WIRB-Copernicus Group
  • Xylem Research LLP
  • Zave Clinical Research Management
Product Code: MRR-8C74ADFBFDA3

The Clinical Trials Site Management Organizations Market was valued at USD 6.86 billion in 2023, expected to reach USD 7.31 billion in 2024, and is projected to grow at a CAGR of 6.85%, to USD 10.91 billion by 2030.

Clinical Trials Site Management Organizations (SMOs) play a crucial role in the administration and management of clinical trials by managing and conducting research on behalf of sponsors. The scope of SMOs includes site selection, recruitment, data management, and regulatory compliance, easing the clinical trial process for pharmaceutical and biotechnology companies. The necessity for SMOs arises from the increasing complexity of clinical trials, geographic expansion, and the need for patient recruitment and retention efficiency. Applications are widespread across phases of clinical trials (I-IV), focusing on therapeutic areas like oncology, cardiology, CNS, and infectious diseases. End-use demand is significant among biopharmaceutical companies, academic institutions, and contract research organizations.

KEY MARKET STATISTICS
Base Year [2023] USD 6.86 billion
Estimated Year [2024] USD 7.31 billion
Forecast Year [2030] USD 10.91 billion
CAGR (%) 6.85%

Key growth drivers include the rising number of clinical trials due to increased R&D activities, outsourcing trends, and technological advancements like AI and big data analytics enhancing site selection and patient recruitment. Potential opportunities lie in expanding partnerships with CROs and developing specialized services in high-demand therapeutic areas. Recommendations to capitalize on these include strategic collaborations and investment in digital solutions to improve trial efficiency and reduce costs. However, the market faces limitations such as stringent regulatory requirements, delays in trial timelines, and competitive pressures leading to pricing challenges. Additionally, integrating emerging technologies poses a challenge due to the complexity and cost of implementation.

Innovative areas include patient-centric trial designs, adaptive trial frameworks, and the integration of wearable technology for real-time monitoring. Research into decentralized trial models could provide a competitive edge. The market is expected to exhibit dynamic growth, driven by globalization and a focus on rare diseases, demanding ever-adaptive research and management strategies. Companies must focus on building robust networks, advancing data analytics capabilities, and fostering collaborations with technology providers to ensure scalability and responsiveness to evolving market needs.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Clinical Trials Site Management Organizations Market

The Clinical Trials Site Management Organizations Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing risk of health issues and growing number of clinical trials
    • Rising private and public investments in pharmaceutical research across the globe
    • Strong clinical trial regulatory frameworks and need for cost-effective management services
  • Market Restraints
    • Complexities associated with multi-site communication and coordination
  • Market Opportunities
    • Integration of advanced technologies in clinical trial site management operations
    • Expansion of clinical trial research facilities with improving healthcare infrastructure
  • Market Challenges
    • Ethical concerns associated with patient data and safety

Porter's Five Forces: A Strategic Tool for Navigating the Clinical Trials Site Management Organizations Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Clinical Trials Site Management Organizations Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Clinical Trials Site Management Organizations Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Clinical Trials Site Management Organizations Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Clinical Trials Site Management Organizations Market

A detailed market share analysis in the Clinical Trials Site Management Organizations Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Clinical Trials Site Management Organizations Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Clinical Trials Site Management Organizations Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Clinical Trials Site Management Organizations Market

A strategic analysis of the Clinical Trials Site Management Organizations Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Clinical Trials Site Management Organizations Market, highlighting leading vendors and their innovative profiles. These include Accel Clinical Services, Accelagen, Altasciences, Celerion, ClinChoice, Clinical Development Solutions, CMIC HOLDINGS Co., LTD., Criterium, Inc., FIDELIS RESEARCH AD by BioIVT, FOMAT Medical Research Inc., George Clinical Pty Ltd, Grand Pacific CRO, ICON PLC, IQVIA Inc., KV Clinical Research Services, L.E.K. Consulting LLC, Medigence Solutions Pvt Ltd., Novotech Health Holdings, Parexel International Corporation, PPD Inc. by Thermo Fisher Scientific Inc., PROMETRIKA, LLC., ProTrials Research, Inc., Red Maple Trials Inc., SGS S.A., Veristat, LLC., Vial Health Technology, Inc., WIRB-Copernicus Group, Xylem Research LLP, and Zave Clinical Research Management.

Market Segmentation & Coverage

This research report categorizes the Clinical Trials Site Management Organizations Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Phase, market is studied across Phase I, Phase II, Phase III, and Phase IV.
  • Based on Services, market is studied across Onsite Monitoring, Project Management, Regulatory Compliance, and Site Management.
  • Based on Therapeutic Areas, market is studied across Cardiology, Central Nervous System, Endocrine, Oncology, and Pain Management.
  • Based on End User, market is studied across Biotechnology Companies, Pharmaceutical Companies, and Research & Academic Institutions.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing risk of health issues and growing number of clinical trials
      • 5.1.1.2. Rising private and public investments in pharmaceutical research across the globe
      • 5.1.1.3. Strong clinical trial regulatory frameworks and need for cost-effective management services
    • 5.1.2. Restraints
      • 5.1.2.1. Complexities associated with multi-site communication and coordination
    • 5.1.3. Opportunities
      • 5.1.3.1. Integration of advanced technologies in clinical trial site management operations
      • 5.1.3.2. Expansion of clinical trial research facilities with improving healthcare infrastructure
    • 5.1.4. Challenges
      • 5.1.4.1. Ethical concerns associated with patient data and safety
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Phase: Need for ensuring the rigorous data collection and participant management in Phase III trials
    • 5.2.2. Therapeutic Areas: Inherent complexities of oncology studies and the need for rapid development cycles and extensive multi-site coordination
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Clinical Trials Site Management Organizations Market, by Phase

  • 6.1. Introduction
  • 6.2. Phase I
  • 6.3. Phase II
  • 6.4. Phase III
  • 6.5. Phase IV

7. Clinical Trials Site Management Organizations Market, by Services

  • 7.1. Introduction
  • 7.2. Onsite Monitoring
  • 7.3. Project Management
  • 7.4. Regulatory Compliance
  • 7.5. Site Management

8. Clinical Trials Site Management Organizations Market, by Therapeutic Areas

  • 8.1. Introduction
  • 8.2. Cardiology
  • 8.3. Central Nervous System
  • 8.4. Endocrine
  • 8.5. Oncology
  • 8.6. Pain Management

9. Clinical Trials Site Management Organizations Market, by End User

  • 9.1. Introduction
  • 9.2. Biotechnology Companies
  • 9.3. Pharmaceutical Companies
  • 9.4. Research & Academic Institutions

10. Americas Clinical Trials Site Management Organizations Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Clinical Trials Site Management Organizations Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Clinical Trials Site Management Organizations Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Pinnacle Clinical Research acquires Jubilee , boosting West Coast presence and expanding therapeutic expertise
    • 13.3.2. IQVIA's innovative platform streamlines clinical trial management by unifying essential research systems
    • 13.3.3. AHP invests in prolerity clinical research to bolster therapeutic expertise and site network expansion across strategic locations
    • 13.3.4. Ichor Life Sciences Expands Its Horizon Through the Launch of Ichor Clinical Trial Services
    • 13.3.5. Strategic Alliance between LEO Pharma and ICON plc Bolsters Innovative Dermatology Clinical Trials
    • 13.3.6. Neutra Executes LOI to Acquire Private Clinical Research
  • 13.4. Strategy Analysis & Recommendation
    • 13.4.1. IQVIA Inc.

Companies Mentioned

  • 1. Accel Clinical Services
  • 2. Accelagen
  • 3. Altasciences
  • 4. Celerion
  • 5. ClinChoice
  • 6. Clinical Development Solutions
  • 7. CMIC HOLDINGS Co., LTD.
  • 8. Criterium, Inc.
  • 9. FIDELIS RESEARCH AD by BioIVT
  • 10. FOMAT Medical Research Inc.
  • 11. George Clinical Pty Ltd
  • 12. Grand Pacific CRO
  • 13. ICON PLC
  • 14. IQVIA Inc.
  • 15. KV Clinical Research Services
  • 16. L.E.K. Consulting LLC
  • 17. Medigence Solutions Pvt Ltd.
  • 18. Novotech Health Holdings
  • 19. Parexel International Corporation
  • 20. PPD Inc. by Thermo Fisher Scientific Inc.
  • 21. PROMETRIKA, LLC.
  • 22. ProTrials Research, Inc.
  • 23. Red Maple Trials Inc.
  • 24. SGS S.A.
  • 25. Veristat, LLC.
  • 26. Vial Health Technology, Inc.
  • 27. WIRB-Copernicus Group
  • 28. Xylem Research LLP
  • 29. Zave Clinical Research Management

LIST OF FIGURES

  • FIGURE 1. CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET RESEARCH PROCESS
  • FIGURE 2. CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET DYNAMICS
  • TABLE 7. GLOBAL CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE I, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE II, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE III, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE IV, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY ONSITE MONITORING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PROJECT MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY REGULATORY COMPLIANCE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SITE MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY ENDOCRINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 40. CANADA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 41. CANADA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 44. MEXICO CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 45. MEXICO CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 46. MEXICO CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 47. MEXICO CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 49. UNITED STATES CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 50. UNITED STATES CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 51. UNITED STATES CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 52. UNITED STATES CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 54. ASIA-PACIFIC CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 55. ASIA-PACIFIC CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 56. ASIA-PACIFIC CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 57. ASIA-PACIFIC CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 58. AUSTRALIA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 59. AUSTRALIA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 60. AUSTRALIA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 61. AUSTRALIA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 62. CHINA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 63. CHINA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 64. CHINA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 65. CHINA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 66. INDIA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 67. INDIA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 68. INDIA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 69. INDIA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 70. INDONESIA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 71. INDONESIA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 72. INDONESIA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 73. INDONESIA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 74. JAPAN CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 75. JAPAN CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 76. JAPAN CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 77. JAPAN CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 78. MALAYSIA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 79. MALAYSIA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 80. MALAYSIA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 81. MALAYSIA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 82. PHILIPPINES CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 83. PHILIPPINES CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 84. PHILIPPINES CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 85. PHILIPPINES CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 86. SINGAPORE CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 87. SINGAPORE CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 88. SINGAPORE CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 89. SINGAPORE CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 90. SOUTH KOREA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 91. SOUTH KOREA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 92. SOUTH KOREA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 93. SOUTH KOREA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 94. TAIWAN CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 95. TAIWAN CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 96. TAIWAN CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 97. TAIWAN CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 98. THAILAND CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 99. THAILAND CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 100. THAILAND CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 101. THAILAND CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 102. VIETNAM CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 103. VIETNAM CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 104. VIETNAM CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 105. VIETNAM CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 109. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 110. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 111. DENMARK CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 112. DENMARK CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 113. DENMARK CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 114. DENMARK CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 115. EGYPT CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 116. EGYPT CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 117. EGYPT CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 118. EGYPT CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 119. FINLAND CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 120. FINLAND CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 121. FINLAND CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 122. FINLAND CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 123. FRANCE CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 124. FRANCE CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 125. FRANCE CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 126. FRANCE CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 127. GERMANY CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 128. GERMANY CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 129. GERMANY CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 130. GERMANY CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 131. ISRAEL CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 132. ISRAEL CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 133. ISRAEL CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 134. ISRAEL CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 135. ITALY CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 136. ITALY CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 137. ITALY CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 138. ITALY CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 139. NETHERLANDS CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 140. NETHERLANDS CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 141. NETHERLANDS CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 142. NETHERLANDS CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 143. NIGERIA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 144. NIGERIA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 145. NIGERIA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 146. NIGERIA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 147. NORWAY CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 148. NORWAY CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 149. NORWAY CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 150. NORWAY CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 151. POLAND CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 152. POLAND CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 153. POLAND CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 154. POLAND CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 155. QATAR CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 156. QATAR CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 157. QATAR CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 158. QATAR CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 159. RUSSIA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 160. RUSSIA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 161. RUSSIA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 162. RUSSIA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 163. SAUDI ARABIA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 164. SAUDI ARABIA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 165. SAUDI ARABIA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 166. SAUDI ARABIA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 167. SOUTH AFRICA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 168. SOUTH AFRICA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 169. SOUTH AFRICA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 170. SOUTH AFRICA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 171. SPAIN CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 172. SPAIN CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 173. SPAIN CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 174. SPAIN CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 175. SWEDEN CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 176. SWEDEN CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 177. SWEDEN CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 178. SWEDEN CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 179. SWITZERLAND CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 180. SWITZERLAND CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 181. SWITZERLAND CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 182. SWITZERLAND CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 183. TURKEY CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 184. TURKEY CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 185. TURKEY CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 186. TURKEY CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED ARAB EMIRATES CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED ARAB EMIRATES CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED ARAB EMIRATES CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED ARAB EMIRATES CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 191. UNITED KINGDOM CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 192. UNITED KINGDOM CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 193. UNITED KINGDOM CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 194. UNITED KINGDOM CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 195. CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 196. CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET, FPNV POSITIONING MATRIX, 2023